000 01298 a2200349 4500
005 20250513100449.0
264 0 _c19961125
008 199611s 0 0 eng d
022 _a0163-7258
024 7 _a10.1016/0163-7258(96)00002-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzyf, M
245 0 0 _aThe DNA methylation machinery as a target for anticancer therapy.
_h[electronic resource]
260 _bPharmacology & therapeutics
_c1996
300 _a1-37 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBase Composition
650 0 4 _aBinding, Competitive
650 0 4 _aDNA Methylation
_xdrug effects
650 0 4 _aDNA Modification Methylases
_xgenetics
650 0 4 _aDNA Replication
_xgenetics
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aGenetic Therapy
650 0 4 _aGenome
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aSignal Transduction
_xgenetics
650 0 4 _aTranscription Factors
_xgenetics
773 0 _tPharmacology & therapeutics
_gvol. 70
_gno. 1
_gp. 1-37
856 4 0 _uhttps://doi.org/10.1016/0163-7258(96)00002-2
_zAvailable from publisher's website
999 _c8798955
_d8798955